← 返回事件持续讨论商业AstraZeneca's experimental COPD drug aced late-stage trials, boosting blockbuster sales hopes图：QuartzCOPD发生了什么The drug reduced flare-ups in a broader patient population than existing COPD biologics, with U.S. approval expected in early 2027摘要按规则整理自下方来源原文来源新闻报道AstraZeneca's experimental COPD drug aced late-stage trials, boosting blockbuster sales hopesQQuartz2 小时前
